Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Bayer G4A Partners With Wellthy Therapeutics
2019-10-11 09:00
MabPlex Lauded by Frost & Sullivan for Global Expansion of ADC Contract Manufacturing Services
2019-10-10 21:00
Innovent and Chi-Med Expand Global Collaboration to Evaluate the Combination of Sintilimab and Surufatinib in Solid Tumors
2019-10-10 15:55
CTFH and Insilico Medicine Enter Al Drug Discovery Collaboration Focused On Accelerating First-in-Class Therapeutics, Worth Up to $200 million
2019-10-09 20:58
Datar Cancer Genetics Announces Positive Results With 42.9% Objective Response Rate, and 90.5% Disease Control Rate in Heavily Pre-treated Patients With Ultra-personalised Pan-cancer Treatment Protocol in the RESILIENT Trial
2019-10-09 17:56
World Thrombosis Day Empowers People Around the World to Recognize and Help Prevent Life-Threatening Blood Clots
2019-10-09 12:00
Tim Oldham Appointed as Chief Executive Officer of AdAlta Ltd
2019-10-09 09:42
Breast Cancer: Hormone Therapy Has a Bigger Impact Than Chemotherapy on Women's Quality of Life - Research by Institut Gustave Roussy
2019-10-09 07:00
Chipscreen and Novogene enter a strategic partnership for companion diagnostics development
2019-10-08 20:46
Drugstore Chain Mik Japan Launches International "Samurai Drugstore" Online Store with USD 100,000 Point-Back Campaign
2019-10-08 14:00
Ascletis Appoints Former Novartis Global Head Dr. Handan He as Chief Scientific Officer
2019-10-08 08:00
Innovent Biologics Announces a New Placement Raised HK$2,351.33 Million
2019-10-04 16:11
Successful implementation of ClinSpark® at Phase I unit of a Top-10 Biopharmaceutical company
2019-10-02 23:37
Clarivate Analytics introduces next-generation pre-clinical drug research platform with Cortellis Drug Discovery Intelligence
2019-10-02 01:39
CapsCanada Expands Growth to New State-of-the-Art Facility
2019-10-01 19:00
ESMO 2019: CStone presents pooled safety data from the Phase 1b trial of CS1001, demonstrating promising overall safety and tolerability
2019-09-30 18:29
Ascletis Announces Departure of Chief Financial Officer
2019-09-30 16:30
Interleukin 11 Identified as New Therapeutic Target for Idiopathic Pulmonary Fibrosis
2019-09-30 15:00
Data From Ascensia Diabetes Care Shows High Accuracy of the CONTOUR®PLUS and CONTOUR®PLUS ONE BGMS in Low Blood Glucose Range and Potential Benefits From Using the CONTOUR®PLUS ONE BGMS With the Health2Sync App
2019-09-30 09:00
Simcere and JW Pharmaceutical Announce Collaboration and License Agreement for Anti-Gout Drug Candidate URC-102 in China
2019-09-27 18:52
1
188
189
190
191
192
246